BR9703499A - Emprego de derivados de teofilina para o tratamento e profilaxia de estados de choque novos compostos de xantina e processo para a sua preparação - Google Patents

Emprego de derivados de teofilina para o tratamento e profilaxia de estados de choque novos compostos de xantina e processo para a sua preparação

Info

Publication number
BR9703499A
BR9703499A BR9703499A BR9703499A BR9703499A BR 9703499 A BR9703499 A BR 9703499A BR 9703499 A BR9703499 A BR 9703499A BR 9703499 A BR9703499 A BR 9703499A BR 9703499 A BR9703499 A BR 9703499A
Authority
BR
Brazil
Prior art keywords
prophylaxis
preparation
treatment
states new
xanthine compounds
Prior art date
Application number
BR9703499A
Other languages
English (en)
Inventor
Ulrich Gebert
Eerhard Wolf
John J Grome
Karl Rudolph
Hiristo Anagnostopulos
Elisabeth Defossa
Uwe Heinelt
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19622737A external-priority patent/DE19622737A1/de
Priority claimed from DE1996129815 external-priority patent/DE19629815A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BR9703499A publication Critical patent/BR9703499A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9703499A 1996-06-07 1997-06-09 Emprego de derivados de teofilina para o tratamento e profilaxia de estados de choque novos compostos de xantina e processo para a sua preparação BR9703499A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19622737A DE19622737A1 (de) 1996-06-07 1996-06-07 Verwendung von Theophyllinderivaten zur Behandlung und Prophylaxe von Schockzuständen, neue Xanthinverbindungen und Verfahren zu deren Herstellung
DE1996129815 DE19629815A1 (de) 1996-07-24 1996-07-24 Verwendung von Theophyllinderivaten zur Behandlung und Prophylaxe von Schockzuständen, neue Xanthinverbindungen und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
BR9703499A true BR9703499A (pt) 1998-10-06

Family

ID=26026372

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9703499A BR9703499A (pt) 1996-06-07 1997-06-09 Emprego de derivados de teofilina para o tratamento e profilaxia de estados de choque novos compostos de xantina e processo para a sua preparação

Country Status (26)

Country Link
US (1) US6214992B1 (pt)
EP (1) EP0812844B1 (pt)
JP (1) JP4156687B2 (pt)
KR (1) KR100477177B1 (pt)
CN (1) CN1066146C (pt)
AR (1) AR007506A1 (pt)
AT (1) ATE226583T1 (pt)
AU (1) AU712277B2 (pt)
BR (1) BR9703499A (pt)
CA (1) CA2207120C (pt)
CZ (1) CZ292205B6 (pt)
DE (1) DE59708533D1 (pt)
DK (1) DK0812844T3 (pt)
ES (1) ES2185837T3 (pt)
HU (2) HU224958B1 (pt)
ID (1) ID19469A (pt)
IL (1) IL120997A (pt)
MX (1) MX9704203A (pt)
MY (1) MY117910A (pt)
NO (1) NO312400B1 (pt)
NZ (1) NZ328017A (pt)
PL (1) PL186576B1 (pt)
PT (1) PT812844E (pt)
RU (1) RU2201930C2 (pt)
SI (1) SI0812844T1 (pt)
TW (1) TW520285B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703044D0 (en) 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
FR2804867B1 (fr) * 2000-02-15 2002-09-20 Hoechst Marion Roussel Inc Application de derives de xanthine pour la preparation d'un medicament destine a la prevention ou au traitement de l'osteoporose
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
UA80258C2 (en) * 2001-09-06 2007-09-10 Biogen Inc Methods of treating pulmonary disease
JP2005529934A (ja) * 2002-05-31 2005-10-06 シェーリング　コーポレイション キサンチンホスホジエステラーゼｖインヒビターおよびその前駆物質を調製するプロセス
SI1509525T1 (sl) * 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
CN112500413B (zh) * 2020-10-13 2024-03-01 安徽中医药大学 一类黄嘌呤芳酸醚衍生物，其制备方法及用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735898A (en) 1985-07-16 1988-04-05 The University Of Virginia Alumini Patents Foundation Monoclonal antibodies and method of identifying species using the same
US4904472A (en) * 1987-04-10 1990-02-27 The University Of Virginia Alumni Patent Foundation Use of adenosine antagonists in the treatment of bradyarrhythmias and mechanical dysfunction associated with cardiopulmonary resuscitation
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
JPH03167186A (ja) * 1989-11-24 1991-07-19 Hokuriku Seiyaku Co Ltd キサンチン誘導体及びその用途
US5036683A (en) * 1990-06-04 1991-08-06 Geuvjehizian Moushegh Y Steering wheel lock protector
DE4019571A1 (de) * 1990-06-20 1992-01-02 Hoechst Ag Pharmazeutische kombinationspraeparate enthaltend cephalosporin- und xanthinderivate und deren verwendung
DE19540798A1 (de) * 1995-11-02 1997-05-07 Hoechst Ag Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
EP0812844A2 (de) 1997-12-17
MY117910A (en) 2004-08-30
HU9701016D0 (en) 1997-07-28
ES2185837T3 (es) 2003-05-01
AU712277B2 (en) 1999-11-04
ID19469A (id) 1998-07-16
TW520285B (en) 2003-02-11
IL120997A0 (en) 1997-11-20
HUP9701016A3 (en) 2004-11-29
NZ328017A (en) 2001-05-25
PL186576B1 (pl) 2004-01-30
SI0812844T1 (en) 2003-02-28
HUP9701016A2 (hu) 1998-12-28
CZ174397A3 (en) 1997-12-17
PT812844E (pt) 2003-03-31
EP0812844B1 (de) 2002-10-23
US6214992B1 (en) 2001-04-10
IL120997A (en) 2001-06-14
NO312400B1 (no) 2002-05-06
HU225040B1 (en) 2006-05-29
CN1066146C (zh) 2001-05-23
HU224958B1 (en) 2006-04-28
ATE226583T1 (de) 2002-11-15
DK0812844T3 (da) 2003-02-17
NO972582D0 (no) 1997-06-06
CA2207120A1 (en) 1997-12-07
NO972582L (no) 1997-12-08
PL320413A1 (en) 1997-12-08
MX9704203A (es) 1998-04-30
JPH1059969A (ja) 1998-03-03
EP0812844A3 (de) 1998-04-08
CN1169993A (zh) 1998-01-14
KR100477177B1 (ko) 2005-09-30
CZ292205B6 (cs) 2003-08-13
RU2201930C2 (ru) 2003-04-10
AR007506A1 (es) 1999-11-10
DE59708533D1 (de) 2002-11-28
JP4156687B2 (ja) 2008-09-24
AU2469897A (en) 1997-12-11
KR980008230A (ko) 1998-04-30
CA2207120C (en) 2007-05-08
HU0500865D0 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
PT93785A (pt) Processo para a preparacao de derivados de 3-substituido-2-oxindole
PT89543A (pt) Processo para a preparacao de extractos de tabaco
BR9408463A (pt) Novos derivados de ginkgolide e processo para sua preparação
PT88099A (pt) Processo para a preparacao de composicoes farmaceuticas de acetaminofeno orais e de libertacao prolongada
PT97433A (pt) Processo para a preparacao de sacarose-6-ester
FI953981A0 (fi) 2-Bentsyyli-polysykliset guaniinijohdannaiset ja menetelmä niiden valmistamiseksi
PT98638A (pt) Processo para a preparacao de derivados de borsolina
PT87707A (pt) Processo para a preparacao de derivados de 2-anilino-pirimidina
PT89205A (pt) Processo para a preparacao de derivados de indano
PT831098E (pt) Intermediarios e processo para a preparacao de olanzapina
BR8902915A (pt) Composicao microbicida e processo para a preparacao de compostos
BR9301180A (pt) Processo para a preparacao de isocianatos e emprego
BR9600149A (pt) 2-(2-N-alcoxifenil)-purin-6-onas 9-substituídas processo para sua preparação medicamantos e uso
PT88181A (pt) Processo para a preparacao de derivados aralquilaminoalcoxifenilo
PT812844E (pt) Utilizacao de derivados de teofilina para o tratamento e profilaxia de estados de choque novos compostos de xantina e processo para a sua preparacao
BR9100907A (pt) Aplicacao de compostos e processo para a preparacao de poliuretanas
PT91027A (pt) Processo para a preparacao de derivados peptidicos
BR8801529A (pt) Processo para o tratamento de lama residual e aparelho para tratamento de lama de tinta
PT89809A (pt) Processo para a preparacao de pirimidinas substituidas
PT93033A (pt) Processo para a preparacao de derivados de guanidina
PT89954A (pt) Processo para a preparacao de pirroloquinolina-e pirrolofenotiazina-carboxamidas e de compostos afins
PT91401A (pt) Processo para a preparacao de compostos de benzodiazepina
BR9007461A (pt) Processo para a preparacao de pigmentos azo
PT99249A (pt) Processo para a preparacao de derivados de piperazina
BR9307043A (pt) Processo para preparação de dinitro-tolueno

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADO DE INT.CL: C07D 473/04; C07D 473/06; A61K 31/522; A61P 9/02

Ipc: C07D 473/04 (2008.01), C07D 473/06 (2008.01), A61K

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO UMA VEZ QUE A MATERIA REIVINDICADA NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA COMO DISPOSTO NOS ARTS. 8O E 13 LPI 9279/96

B12B Appeal against refusal [chapter 12.2 patent gazette]